Regulation of NK cell functions through interaction of the CD94/NKG2 receptors with the nonclassical class I molecule HLA-E.

Regulation of NK cell functions through interaction of the CD94/NKG2 receptors with the nonclassical class I molecule HLA-E.

Bibliographic Details
Main Authors:	Braud, V, Mcmichael, A
Format:	Journal article
Language:	English
Published:	1999

Similar Items

HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells.
by: King, A, et al.
Published: (2000)

HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
by: Braud, V, et al.
Published: (1998)

CD94/NKG2 is the predominant inhibitory receptor involved in recognition of HLA-G by decidual and peripheral blood NK cells.
by: Söderström, K, et al.
Published: (1997)

HLA class I signal peptide polymorphism determines the level of CD94/NKG2–HLA-E-mediated regulation of effector cell responses
by: Lin, Z, et al.
Published: (2023)

Functions of nonclassical MHC and non-MHC-encoded class I molecules.
by: Braud, V, et al.
Published: (1999)

High-throughput characterization of HLA-E-presented CD94/NKG2x ligands reveals peptides which modulate NK cell activation
by: Huisman, BD, et al.
Published: (2023)

High-throughput characterization of HLA-E-presented CD94/NKG2x ligands reveals peptides which modulate NK cell activation
by: Brooke D. Huisman, et al.
Published: (2023-08-01)

Requirement of the proteasome for the trimming of signal peptide-derived epitopes presented by the nonclassical major histocompatibility complex class I molecule HLA-E.
by: Bland, F, et al.
Published: (2003)

Enriched HLA-E and CD94/NKG2A interaction limits antitumor CD8+ tumor-infiltrating T lymphocyte responses
by: Abd Hamid, M, et al.
Published: (2019)

Publisher Correction: High-throughput characterization of HLA-E-presented CD94/NKG2x ligands reveals peptides which modulate NK cell activation
by: Brooke D. Huisman, et al.
Published: (2023-08-01)

Enriched HLA-E and CD94/NKG2a interaction limits anti-tumor CD8+ tumor-infiltrating T lymphocyte responses
by: Abd Hamid, M, et al.
Published: (2019)

Structural features impose tight peptide binding specificity in the nonclassical MHC molecule HLA-E.
by: O'Callaghan, C, et al.
Published: (1998)

Differential expression of NK receptors CD94 and NKG2A by T cells in rheumatoid arthritis patients in remission compared to active disease.
by: Ceara E Walsh, et al.
Published: (2011-01-01)

CD94-driven in vitro expansion of highly functional adaptive NKG2C+ NKG2A- CD57+ NK cells from CMV+ healthy donors
by: Chiara Giordano, et al.
Published: (2025-01-01)

Immune checkpoints HLA-E:CD94-NKG2A and HLA-C:KIR2DL1 complementarily shield circulating tumor cells from NK-mediated immune surveillance
by: Xiaowei Liu, et al.
Published: (2024-02-01)

BLOCKING THE INHIBITORY CD94/NKG2A NK CELL RECEPTOR WITH A NOVEL ANTI-NKG2A MAB ENHANCES THE SUSCEPTIBILITY OF RHEUMATOID ARTHRITIS FIBROBLAST-LIKE SYNOVIOCYTES (FLS) TO NK CELL-MEDIATED CYTOTOXICITY
by: Nielsen, N, et al.
Published: (2012)

Elusive Role of the CD94/NKG2C NK Cell Receptor in the Response to Cytomegalovirus: Novel Experimental Observations in a Reporter Cell System
by: Aldi Pupuleku, et al.
Published: (2017-10-01)

Expression of the Classical and Nonclassical HLA Molecules in Breast Cancer
by: Gisela Bevilacqua Rolfsen Ferreira da Silva, et al.
Published: (2013-01-01)

Natural killer cell surveillance of intracellular antigen processing pathways mediated by recognition of HLA-E and Qa-1b by CD94/NKG2 receptors.
by: O'Callaghan, C
Published: (2000)

A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition.
by: Michaëlsson, J, et al.
Published: (2002)

Regulation of NK-Cell Function by HLA Class II
by: Annika Niehrs, et al.
Published: (2020-02-01)

NKG2D and DNAM-1 activating receptors and their ligands in NK-T cell interactions: role in the NK cell-mediated negative regulation of T cell responses
by: Alessandra eZingoni, et al.
Published: (2013-01-01)

Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules.
by: Colonna, M, et al.
Published: (1998)

S256: HLA-E/NKG2A CHECKPOINT DRIVES MULTIPLE MYELOMA RESISTANCE TO CAR-NK THERAPY
by: Jessica Encinas, et al.
Published: (2023-08-01)

The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9.
by: Braud, V, et al.
Published: (1997)

Chronic NKG2D Engagement In Vivo Differentially Impacts NK Cell Responsiveness by Activating NK Receptors
by: Christine Koch, et al.
Published: (2017-11-01)

What a Difference an Amino Acid Makes: An All-Atom Simulation Study of Nonameric Peptides in Inhibitory HLA-E/NKG2A/CD94 Immune Complexes
by: Eva Prašnikar, et al.
Published: (2022-08-01)

Bispecific NKG2D-CD3 and NKG2D-CD16 fusion proteins for induction of NK and T cell reactivity against acute myeloid leukemia
by: Melanie Märklin, et al.
Published: (2019-05-01)

Human Cytomegalovirus Antigen Presentation by HLA-DR+ NKG2C+ Adaptive NK Cells Specifically Activates Polyfunctional Effector Memory CD4+ T Lymphocytes
by: Marcel Costa-García, et al.
Published: (2019-04-01)

Disruption of the NKG2A:HLA-E Immune Checkpoint Axis to Enhance NK Cell Activation against Cancer
by: Jack G. Fisher, et al.
Published: (2022-11-01)

Evidence of widespread binding of HLA class I molecules to peptides.
by: Frelinger, J, et al.
Published: (1990)

Immune recognition of HLA molecules downmodulates CD8 expression on cytotoxic T lymphocytes.
by: Robbins, P, et al.
Published: (1991)

CD8+ T lymphocytes are sensitive to NKG2A/HLA-E licensing interaction: role in the survival of cancer patients
by: Lourdes Gimeno, et al.
Published: (2021-01-01)

Identification of the nonclassical HLA molecules, mica, as targets for humoral immunity associated with irreversible rejection of kidney allografts.
by: Sumitran-Holgersson, S, et al.
Published: (2002)

Activating and inhibitory receptors on synovial fluid natural killer cells of arthritis patients: role of CD94/NKG2A in control of cytokine secretion.
by: de Matos, C, et al.
Published: (2007)

A herpesvirus encoded Qa-1 mimic inhibits natural killer cell cytotoxicity through CD94/NKG2A receptor engagement
by: Xiaoli Wang, et al.
Published: (2018-12-01)

Unlocking the therapeutic potential of the NKG2A-HLA-E immune checkpoint pathway in T cells and NK cells for cancer immunotherapy
by: Yan Li, et al.
Published: (2024-10-01)

Dynamic shift from CD85j/ILT-2 to NKG2D NK receptor expression pattern on human decidual NK during the first trimester of pregnancy.
by: Romain Marlin, et al.
Published: (2012-01-01)

Expression of a single-chain HLA class I molecule in a human cell line: presentation of exogenous peptide and processed antigen to cytotoxic T lymphocytes.
by: Toshitani, K, et al.
Published: (1996)

A Conserved HIV-1-Derived Peptide Presented by HLA-E Renders Infected T-cells Highly Susceptible to Attack by NKG2A/CD94-Bearing Natural Killer Cells.
by: Zachary B Davis, et al.
Published: (2016-02-01)